![Gregor Vlasak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregor Vlasak
Private-Equity-Analyst bei
Apax Partners (UK) Ltd.
Profil
Gregor Vlasak is a Principal in the Healthcare team.
He joined Apax Partners in 2017 and is currently based in London.
Gregor has participated in key deals including Rodenstock, Neuraxpharm, Candela and Vyaire.
Prior to joining Apax Partners, Gregor worked at the Healthcare teams of Perella Weinberg Partners and J.P.
Morgan, where he advised clients on M&A transactions.
Gregor holds an MSc in Accounting and Financial Management from Stockholm School of Economics, and a BSc in Business from the University of Mannheim.
Aktive Positionen von Gregor Vlasak
| Unternehmen | Position | Beginn |
|---|---|---|
Apax Partners (UK) Ltd.
 Apax Partners (UK) Ltd. Investment ManagersFinance Apax Partners invests in both companies located across the globe. The firm targets companies operating in the fields of technology, service and internet/consumer sectors. It provides buyout and debt stage capital requirements. | Private-Equity-Analyst | 01.06.2019 |
Ehemalige bekannte Positionen von Gregor Vlasak
| Unternehmen | Position | Ende |
|---|---|---|
| CANDELA MEDICAL, INC. | Direktor/Vorstandsmitglied | 01.08.2022 |
Neuraxpharm Debtco SARL
 Neuraxpharm Debtco SARL Financial ConglomeratesFinance Operates as a financial holding company | Direktor/Vorstandsmitglied | 01.12.2020 |
Ausbildung von Gregor Vlasak
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Apax Partners (UK) Ltd.
Apax Partners (UK) Ltd. Investment ManagersFinance Apax Partners invests in both companies located across the globe. The firm targets companies operating in the fields of technology, service and internet/consumer sectors. It provides buyout and debt stage capital requirements. | Finance |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuraxpharm Debtco SARL
Neuraxpharm Debtco SARL Financial ConglomeratesFinance Operates as a financial holding company | Finance |
Candela Medical, Inc.
 Candela Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical aesthetic device company that develops and manufactures medical aesthetic laser, IPL & RF micro needling machines | Health Technology |
Wählen Sie MarketScreener 
